Hyperthermy Endocavitary Treatment in Pelvic Pain
This trial is active, not recruiting.
|Treatment||hyperthermy treatment with mjs electrode|
|Phase||phase 1/phase 2|
|Sponsor||Universidad Rey Juan Carlos|
|Collaborator||Hospital Universitario Virgen de la Victoria|
|Start date||August 2015|
|End date||December 2016|
|Trial size||60 participants|
|Trial identifier||NCT02837588, Hyperthermy pelvic floor|
- Treatment at pelvic floor with hyperactivity with hyperthermy electrode MJS
- MJS electrode is effective for transvaginal treatment at pelvic pain patients
- Hyperthermy treatment with MJS electrode is more effective to usual drugs treatment
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
|Masking||single blind (caregiver)|
time frame: four weeks
pain measure questionnaire
time frame: four weeks
Female participants from 18 years up to 80 years old.
Inclusion Criteria: - Women with chronic pelvic pain Exclusion Criteria: - chronic pelvic pain or neurological degenerative etiology - Presence of pathology or infectious processes genitourinary level - possibility of pregnancy or lactating. - Lack of informed consent, mental disorders, dementia, dependent people who need tutor.
|Official title||Endocavitary Radiofrequency Treatment in Patients Who Present With Chronic Pelvic Pain Compared to Usual Drug Therapy|
|Description||This study analyzed the evolution of chronic pelvic pain, defined by the different map of myofascial trigger points assets presents the patient with medical treatment compared to treatment with radiofrequency endocavitary electrode MJS. The initial evaluator analyzed by the NIH-CPSI Scale questionnaire and symptoms of chronic pelvic pain Stanford Protocol for female or male quality of life of the patient before the doctor or radio frequency and a month since treatment. the patient to the Principal Investigator, specialist physiotherapist, who appreciates tenderness the presence of a taut band with a map of pain in endopelvic and exopelvic muscles, determining the activation of myofascial trigger points in each is derived. The Principal Investigator proceeds to address each active myofascial trigger points with the MJS electrode four 20-minute sessions twice a week. The MJS has a curved end pressure which favors the compression point plus the location and accurate approach Radiofrequency pathological point as outstanding feature. The high specificity of myofascial treatment offered by the MJS electrode involves no danger, besides having the computer screen conductivity meter and a temperature sensor on the head to control both parameters in real time during the treatment session|
Call for more information